Profit

Sun Pharma May Test Rs 760-780 on Downside: Aditya Agarwal

PUBLISHED ON: March 28, 2016 | Duration: 5 min, 46 sec

facebooktwitteremailkoo
loading..
Aditya Agarwal, head technical research at Way2wealth, says Sun Pharma has closed below a crucial support at Rs 820 and selling pressure in the stock may continue going ahead. The shares may test Rs 780 levels in the short term, he adds.
ALSO WATCH
PAN To Be Used As Common Business Identifier: Centre On Ease of Business

................................ Advertisement ................................

Short videosBy Firework

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com